The Opposite Association of HRAS and KRAS Mutations With Clinical Variables of Bladder Cancer

Vavilov Journal of Genetics and Breeding
doi 10.18699/vj15.081
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Institute of Cytology and Genetics, SB RAS

Related search

FGFR3, HRAS, KRAS, NRAS and PIK3CA Mutations in Bladder Cancer and Their Potential as Biomarkers for Surveillance and Therapy

PLoS ONE
Multidisciplinary
2010English

KRAS, HRAS and EGFR Mutations in Sporadic Sebaceous Gland Hyperplasia

Acta Dermato-Venereologica
DermatologyMedicine
2014English

High Frequency of the HRAS Oncogene Codon 12 Mutation in Macedonian Patients With Urinary Bladder Cancer

Genetics and Molecular Biology
GeneticsMolecular Biology
2004English

Allelic Ratio of KRAS Mutations in Pancreatic Cancer

Oncologist
Cancer ResearchMedicineOncology
2015English

Molecular Pathological Epidemiology of Colorectal Cancer in Chinese Patients With KRAS and BRAF Mutations

Oncotarget
Oncology
2015English

PIK3CA Mutations Frequently Coexist With EGFR/KRAS Mutations in Non-Small Cell Lung Cancer and Suggest Poor Prognosis in EGFR/KRAS Wildtype Subgroup

PLoS ONE
Multidisciplinary
2014English

The Biology and Clinical Management of Bladder Cancer.

Annals of Internal Medicine
Internal MedicineMedicine
1976English

Prevalence of KRAS, BRAF, PI3K and EGFR Mutations Among Asian Patients With Metastatic Colorectal Cancer

Oncology Letters
Cancer ResearchOncology
2015English

KRAS Mutations in Slovene Patients With Colorectal Cancer: Frequency, Distribution and Correlation With the Response to Treatment

International Journal of Oncology
Cancer ResearchOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy